Answers are grounded in this paper and cite their sources.
Per- and polyfluoroalkyl substances (PFAS) are widespread environmental contaminants associated with various adverse health effects, yet the molecular mechanisms underlying PFAS-induced lung injury remain poorly understood, particularly regarding inhalation as a significant exposure route. In this study, we employed an integrated computational and experimental strategy using perfluorooctanesulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) as model compounds, combining network toxicology, molecular docking, and molecular dynamics simulations with validation in cellular (A549) and murine acute lung injury models through histopathology, immunofluorescence, qPCR, Western blot, and functional rescue experiments. Network analysis prioritized five core targets, among which MMP9 and PPARγ ranked as the top hubs, and molecular docking and dynamics simulations predicted stable binding of PFAS to PPARγ. Experimentally, PFAS exposure suppressed PPARγ, activated NF-κB signaling, and upregulated MMP9, collectively driving inflammation, extracellular matrix degradation, and apoptosis. Critically, convergent evidence from pharmacological rescue using the PPARγ agonist rosiglitazone, the NF-κB inhibitor BAY 11-7082, and PPARγ overexpression confirmed PPARγ/NF-κB/MMP9 axis in PFAS-induced pulmonary injury. These findings elucidate a novel mechanism by which PFAS induce lung injury through the PPARγ/NF-κB/MMP9 axis, identifying potential therapeutic targets for the prevention and treatment of PFAS-associated respiratory diseases.
No takes yet. Share an insight, caveat, or question.
Du et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: